Theravance Biopharma TBPH Period Increase Decrease Unrecognized Tax Benefits
Period Increase Decrease Unrecognized Tax Benefits at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept tbph:PeriodIncreaseDecreaseUnrecognizedTaxBenefits.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's period increase decrease unrecognized tax benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's period increase decrease unrecognized tax benefits?
- Theravance Biopharma (TBPH) reported period increase decrease unrecognized tax benefits of $1.47M in Q1 2026.
- How has Theravance Biopharma's period increase decrease unrecognized tax benefits changed year-over-year?
- Theravance Biopharma's period increase decrease unrecognized tax benefits increased by 14.7% year-over-year, from $1.29M to $1.47M.
- What is the long-term trend for Theravance Biopharma's period increase decrease unrecognized tax benefits?
- Over 4 years (2021 to 2025), Theravance Biopharma's period increase decrease unrecognized tax benefits has grown at a 172.9% compound annual growth rate (CAGR), from -$189K to $10.48M.
- What does period increase decrease unrecognized tax benefits mean?
- This represents the change in the liability for uncertain tax positions that do not meet the threshold for recognition in the financial statements. It reflects the company's exposure to potential tax audits and the resolution of tax-related contingencies. Investors track this to assess the company's tax risk profile and potential future cash outflows related to tax settlements.